Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD
Clinical trial NCT02633527 · COMPLETED
Trial details
- NCT number
- NCT02633527
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-07-25
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.